指南与共识泌尿系结石

欧洲泌尿外科学会泌尿系结石诊断与治疗指南

European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis.
指南 / 共识 · Eur Urol · 2025-04-22

欧洲泌尿外科学会泌尿系结石指南基于最新研究证据,围绕风险评估、影像学、药物治疗和手术干预给出推荐并标注推荐强度。诊断以超声为首选、低剂量CT为金标准,治疗按结石大小、位置和成分选择。指南强调个体化管理,并指出预测模型仍需进一步研究完善。

要点

  • 超声为泌尿系结石一线影像学检查,低剂量CT是精确评估结石的金标准。
  • 非甾体抗炎药推荐为一线镇痛,阿片类药物作为二线选择。
  • α受体阻滞剂药物排石治疗可考虑用于部分输尿管结石患者。

核心结论

  • 指南为泌尿系结石临床决策提供框架,同时承认该领域需持续进展。

研究设计与样本

  • 欧洲泌尿外科学会泌尿系结石指南,由研究馆员在Cochrane Library、Medline和Embase数据库经Dialog-Datastar进行文献检索,纳入最新研究证据并对推荐强度进行分级。

主要发现

  • 诊断依赖临床病史、生化评估和影像学组合,超声为一线模态,低剂量CT为精确结石评估的金标准。
  • 结石成分和负荷影响治疗决策,算法主要基于结石大小、位置和成分。
  • 非甾体抗炎药推荐为一线疼痛管理,阿片类药物保留为二线选项。
  • α受体阻滞剂药物排石治疗可考虑用于部分输尿管结石患者。
  • 体外冲击波碎石术、输尿管镜和经皮肾镜取石术仍是主要干预方式,选择基于结石特征和患者因素。

关键数值与推荐

  • 超声为一线影像学模态,低剂量CT为精确结石评估的金标准。
  • 非甾体抗炎药推荐为一线疼痛管理,阿片类药物为二线选项。
  • α受体阻滞剂药物排石治疗可考虑用于部分输尿管结石患者。
  • 推荐对高危患者进行基因检测以指导个体化治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出需要进一步研究以完善预测模型。
  • 原文承认泌尿系结石领域需要持续进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The European Association of Urology urolithiasis guidelines provide evidence-based recommendations for the diagnosis and treatment of urinary stone disease. Given the complexity and variability of stone formation, individualised patient management is emphasised. METHODS: The guidelines incorporate evidence from the latest research and focus on risk assessment, imaging techniques, pharmacological management, and surgical interventions. A research librarian conducted literature searches for urolithiasis in the Cochrane Library, Medline, and Embase databases via Dialog-Datastar. The strength of recommendations is also rated. KEY FINDINGS AND LIMITATIONS: Diagnosis relies on a combination of clinical history, biochemical evaluation, and imaging, with ultrasound as the first-line modality and low-dose computed tomography as the gold standard for precise stone assessment. Stone composition and burden influence treatment decisions with algorithms primarily based on stone size, location, and composition. Nonsteroidal anti-inflammatory drugs are recommended for first-line pain management, with opioids reserved as a secondary option. Medical expulsive therapy with α-blockers may be considered for selected patients with ureteral stones. Extracorporeal shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy remain the primary intervention modalities, with selection based on stone characteristics and patient factors. Advances in multiplanar imaging have improved assessment of the stone burden, although further research is needed to refine predictive models. Genetic testing is recommended for high-risk patients to guide personalised treatment. CONCLUSIONS AND CLINICAL IMPLICATIONS: The guidelines provide a framework for clinical decision-making while acknowledging the need for continued advances in urolithiasis.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Skolarikos A, Geraghty R, Somani B, et al. European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis. Eur Urol. 2025. PMID: 40268592. doi:10.1016/j.eururo.2025.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。